2026 ICD-10-CM Diagnosis Code I77.82Antineutrophilic cytoplasmic antibody [ANCA] vasculitis

ICD-10-CM CodesI00–I99I70-I79I77

ICD-10-CM I77.82
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

I77.82 is a billable ICD-10-CM diagnosis code for antineutrophilic cytoplasmic antibody [ANCA] vasculitis. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 299 through 301. Coders also document this condition as antineutrophil cytoplasmic antibody positive vasculitis. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Other specified and unspecified circulatory disease.

Code Identity

ICD-10-CM Code
I77.82
Billable Status
Yes — Valid for Submission
Code Describes
Antineutrophilic cytoplasmic antibody [ANCA] vasculitis
Short Description
Antineutrophilic cytoplasmic antibody [ANCA] vasculitis
Same as the full description in the CMS dataset.
Parent Code
Other specified disorders of arteries and arterioles

Code Classification

ChapterI00–I99Diseases of the circulatory system
SectionI70-I79Diseases of arteries, arterioles and capillaries
CategoryI77Other disorders of arteries and arterioles
This CodeI77.82Antineutrophilic cytoplasmic antibody [ANCA] vasculitis

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Antineutrophil cytoplasmic antibody positive vasculitis

Tabular List NotesGuidance

Coding notes and annotation back-references applicable to this code.

Inclusion Terms

  • ANCA associated vasculitis
  • ANCA positive vasculitis

Type 2 Excludes

  • eosinophilic granulomatosis with polyangiitis M30.1
  • granulomatosis with polyangiitis M31.3
  • microscopic polyangiitis M31.7

Index to Diseases and InjuriesGuidance

External Cause of Injuries IndexGuidance

References for this code in the External Cause of Injuries Index.

    • Vasculitis
      • ANCA (antineutrophilic cytoplasmic antibody) associated
    • Vasculitis
      • ANCA (antineutrophilic cytoplasmic antibody) positive
    • Vasculitis
      • antineutrophilic cytoplasmic antibody [ANCA]

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR CIR032
Other specified and unspecified circulatory disease
Default principal diagnosis: inpatient Yes · outpatient Yes

Patient EducationClinical

Vasculitis

Vasculitis is an inflammation of the blood vessels. It happens when the body's immune system attacks the blood vessel by mistake. It can happen because of an infection, a medicine, or another disease. The cause is often unknown.

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Code History & ChangesHistory

Replacement I77.82 replaces the following previously assigned code(s):

  • I77.89 - Other specified disorders of arteries and arterioles
FY 2023AddedAdded to the ICD-10-CM code setEffective October 1, 2022.
FY 2024–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About I77.82Overview

Is I77.82 (Other specified disorders of arteries and arterioles) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report antineutrophilic cytoplasmic antibody [ANCA] vasculitis on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What MS-DRG does I77.82 group to?

When antineutrophilic cytoplasmic antibody [ANCA] vasculitis is the principal diagnosis on an inpatient stay, it groups to MS-DRG 299, 300, 301, with relative weights from 0.7197 to 1.6327 depending on complications. Higher weights mean higher Medicare reimbursement.

Footnotes

[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:

  • The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
  • The condition places limitations on self-care, independent living, and social interactions.